Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Lilly raises outlook for third time this year as...
Business & Finance

Lilly raises outlook for third time this year as Zepbound sales soar.

Lilly raises outlook for third time this year as Zepbound sales soar.
MarketWatch Thursday 29 October 2026, 11:03 UTC By Jaimy Lee 1 min read
Key Points

The drug continues do dominate the market for prescription weight-loss drugs in the U.S.

The drug continues do dominate the market for prescription weight-loss drugs in the U.S.
Lilly (ORG) Zepbound (PERSON) U.S. (LOCATION)
Originally published by MarketWatch Read original →

Related Stories

Reunion with Dodgers? Richest contract ever? What's next for Tarik Skubal, MLB's No. 1 free agent

The sudden end to the Los Angeles Dodgers' bid for a three-peat felt especially jarring to Tarik Skubal. The two-time defending American League Cy Young Award winner, acquired in a trade deadline blockbuster from the Detroit Tigers, was scheduled to take the ball for Game 5 of the National League Championship Series. In his mind, he said, there was no doubt he would make that start, keep his new team alive, give the rest of the Dodgers' star-studded rotation another chance and see what would...

ESPN just now

Ohio State backup quarterback Luke Fahey 'has a moxie about him'

COLUMBUS, Ohio -- Stephen Fahey finally got to see the Buckeyes -- and his favorite player, Ohio State quarterback Rex Kern -- play in person at the Rose Bowl on New Year's Day 1971. "I couldn't take my eyes off the guy when he was playing," Stephen said. "I loved the way he just seemed in control of the offense.

ESPN just now

IndiGo CEO says ‘no choice’ but to consider fare hikes as fuel costs surge

IndiGo CEO Willie Walsh has signalled possible fare hikes as rising fuel costs put pressure on the airline's finances, saying the carrier has “no choice” but to consider increasing fares to offset the surge in its fuel bill. According to news agency PTI, Walsh said the airline would continue to trim expenses but cautioned against expecting significant cost-cutting measures. “We will continue to look at measures to trim expenses but should not expect any significant cost measures,” he said.

Times of India 10m ago

Kalshi valuation jumps to $40 billion in latest funding round

Kalshi has completed a $1 billion funding round that values the prediction market exchange at $40 billion, the company announced on Thursday. That valuation comes after it completed its previous funding round in May, where it was valued at $22 billion. The latest round was co-led by Sequoia Capital and Wellington Management.

CNBC 13m ago